Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Prognostic models for overall survival (OS) for patients with metastatic castration-resistant prostate cancer (mCRPC) are dated and do not reflect significant advances in treatment options available for these patients. This work developed and validated an updated prognostic model to predict...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Halabi, Susan, Lin, Chen-Yen, Kelly, W. Kevin, Fizazi, Karim S., Moul, Judd W., Kaplan, Ellen B., Morris, Michael J., Small, Eric J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2014
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927736/
https://ncbi.nlm.nih.gov/pubmed/24449231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.3696
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller